Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma.

Bendamustine (B), which was initially synthesized around 50 years ago in the former East Germany, has become an important drug in combination with rituximab (R) (BR therapy) in the treatment of B-c...